What is iRadimed's revenue?

iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.

Is iRadimed profitable?

iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.

What are iRadimed's profit margins?

Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.

What is iRadimed's earnings per share?

iRadimed's diluted EPS over the trailing twelve months is $1.83.

Where does iRadimed's income statement data come from?

Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

iRadimed IRMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$21.98M-3.1%	$22.69M+7.0%	$21.2M+3.9%	$20.41M+4.6%	$19.51M+0.6%
Total cost of revenue	$5.17M-8.7%	$5.66M+20.2%	$4.71M+5.7%	$4.45M-4.6%	$4.67M+0.9%
Gross profit	$16.81M-1.3%	$17.03M+3.3%	$16.49M+3.4%	$15.95M+7.5%	$14.84M+0.6%
Gross margin	76.5%+1.4pp	75.1%-2.7pp	77.8%-0.4pp	78.2%+2.1pp	76.1%-0.1pp
Research and development	$956K+19.6%	$799.03K+18.5%	$674.36K-23.1%	$877.36K+40.6%	$624K+9.4%
Selling and marketing	$4.05M-12.0%	$4.6M-0.6%	$4.63M+15.5%	$4.01M-4.0%	$4.18M-7.6%
General and administrative	$4.57M+0.7%	$4.54M+4.1%	$4.36M+1.8%	$4.28M-7.2%	$4.61M+19.1%
Total operating expenses	$9.58M-3.6%	$9.94M+2.9%	$9.66M+5.4%	$9.17M-2.6%	$9.41M+5.0%
Operating income	$7.24M+2.0%	$7.09M+3.8%	$6.83M+0.7%	$6.79M+25.0%	$5.43M-6.4%
Operating margin	32.9%+1.7pp	31.3%-1.0pp	32.2%-1.0pp	33.3%+5.4pp	27.8%-2.1pp
Other income (expense), net	$532K-23.7%	$696.8K+50.2%	$463.98K-14.0%	$539.25K+5.1%	$513K-5.6%
Income before income taxes	$7.77M-0.3%	$7.79M+6.8%	$7.3M-0.4%	$7.33M+23.3%	$5.95M-6.3%
Income tax expense	$1.95M+44.7%	$1.35M-21.6%	$1.72M+10.8%	$1.55M+23.5%	$1.26M+5.1%
Net income	$5.82M-9.7%	$6.44M+15.5%	$5.58M-3.4%	$5.77M+23.2%	$4.69M-8.9%
Net margin	26.5%-1.9pp	28.4%+2.1pp	26.3%-2.0pp	28.3%+4.3pp	24%-2.5pp
Diluted earnings per share	$0.45-10.0%	$0.50+16.3%	$0.43-4.4%	$0.45+21.6%	$0.37-7.5%
EBITDA	$7.69M+2.9%	$7.47M+3.6%	$7.22M+3.2%	$7M+24.3%	$5.63M-6.2%
EBITDA margin	35%+2.1pp	32.9%-1.1pp	34%-0.2pp	34.3%+5.4pp	28.8%-2.1pp
EBIT	$7.24M+2.0%	$7.09M+3.8%	$6.83M+0.7%	$6.79M+25.0%	$5.43M-6.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about iRadimed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's revenue?: iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.
Is iRadimed profitable?: iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.
What are iRadimed's profit margins?: Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.
What is iRadimed's earnings per share?: iRadimed's diluted EPS over the trailing twelve months is $1.83.
Where does iRadimed's income statement data come from?: Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.